Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Harmony Biosciences Management, Inc.

Clinical trials sponsored by Harmony Biosciences Management, Inc., explained in plain language.

Harmony Biosciences Management, Inc. HRMY NASDAQ

Develops treatments for rare neurological diseases, including narcolepsy.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 4 Not yet finished but already full! 1 Completed 5

New drug pitolisant tested for safety in rare genetic disorder

Disease control ENROLLING_BY_INVITATION

This phase 3 trial is testing the safety of pitolisant in 150 people with Prader-Willi syndrome who have already taken the drug in a previous study. Participants will receive pitolisant tablets and be monitored for side effects. The goal is to see if pitolisant is safe for long-t…

Phase: PHASE3 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Disease control

Last updated Jun 27, 2026 11:02 UTC